Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

被引：0
|
作者：
Pandya, Bhavik J.
Medeiros, Bruno C.
Chen, Chi-Chang
Wilson, Samuel
Groves, Eric S.
Horvath, Laura Elise
Wade, Rolin L.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2118
引用
收藏
页数：3
相关论文
共 50 条
  • [21] MEDICAL COST ESTIMATION FOR ELDERLY ACUTE MYELOID LEUKEMIA (AML) USING REAL WORLD DATA IN JAPAN
    Kogushi, K.
    Nakamura, K.
    Ikeda, S.
    VALUE IN HEALTH, 2018, 21 : S13 - S13
  • [22] Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)
    Bystrom, Rebecca
    Fernandes, Laura L.
    Wynne, Joseph
    Pulte, Dianne
    Hansen, Eric
    Belli, Andrew J.
    Barcellos, Anna
    Zettler, Christina M.
    Vallejo, Jonathon
    Norsworthy, Kelly
    De Claro, Angelo
    Lerro, Catherine
    Theoret, Marc R.
    Wang, Ching-Kun
    Rivera, Donna
    BLOOD, 2023, 142
  • [23] Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices
    LeBlanc, Thomas W.
    Borham, Azah
    Su, Yun
    Hayes, Karin Chun
    Fielding, Russel
    Benigno, Michael
    Cappelleri, Joseph C.
    BLOOD, 2017, 130
  • [24] A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia
    Hu, Rong-Hua
    Su, Li
    Lan, Xiao-Xi
    Chang, Xiao-Li
    Hui, Wu-Han
    Guo, Yi-Xian
    Zhao, Hong
    Zhang, Yue
    Sun, Wan-Ling
    ANTI-CANCER DRUGS, 2023, 34 (03) : 344 - 350
  • [25] Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia - A Retrospective Study of a Real-World Setting
    Saiz-Rodriguez, Miriam
    Cuevas, Beatriz
    Alvarez, Rodolfo
    Cuello, Rebeca
    Belen Vidriales, Maria
    Olivier, Carmen
    Recio, Isabel
    Campuzano, Veronica
    Yeguas, Ana
    Cuevas, Victoria
    Javier Diaz-Galvez, Francisco
    Ruano, Teresa
    Avendano, Alejandro
    Duenas, Veronica
    Garcia, Covadonga
    Jose Gonzalez-Lopez, Tomas
    Olazabal, Juan
    Serra, Fe
    De Vicente, Pilar
    Hermida, Gerardo
    Labrador, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S173 - S174
  • [26] Real-World Experience with Venetoclax-Based Regimens for the Treatment of Acute Myeloid Leukemia
    Ceparano, Giusy
    Sciume, Mariarita
    Fabris, Sonia
    Barozzi, Enrico
    Rampi, Nicolo
    De Roberto, Pasquale
    Baldini, Luca
    Fracchiolla, Nicola Stefano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S298 - S298
  • [27] Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia
    Dhillon, Vikram
    Khan, Abdul Moiz
    Al Sbihi, Ali
    Reddy, Sushmitha Nanja
    Lalo, Enxhi
    Ramos, Harry
    Yang, Jay
    Kottam, Anupama
    Balasubramanian, Suresh Kumar
    BLOOD, 2022, 140 : 6183 - 6184
  • [28] Real-World Experience of Venetoclax Combination Therapy in Patients with Acute Myeloid Leukemia (AML): A SingleInstitution Retrospective Study in a Middle-Income Country
    Aranguiz, Natalia
    Valladares, Ximena
    Donoso, Javiera
    Ignacio Ewoldt, Sebastian
    Ernst, Daniel
    Diaz, Joaquin
    Sanchez, Matias
    BLOOD, 2022, 140 : 11723 - 11724
  • [29] Real-World Safety and Clinical Response of Flumatinib in the Treatment of Chronic Myeloid Leukemia: A Retrospective Study
    Chen Chunyan
    BLOOD, 2023, 142
  • [30] The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims
    Tabah, Ashley
    Huggar, David
    Brady, Brenna L.
    Jariwala-Parikh, Krutika
    Huey, Krystal
    Copher, Ronda M.
    Leblanc, Thomas W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S181 - S181
12345